Deep brain stimulation versus best medical therapy for PD

Nature Reviews Neurology

Volumn 6, Issue 10, 2010, Pages 530-532

  Brodsky, Matthew A ^a   Nutt, John G ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOMORPHINE; ANTIPARKINSON AGENT;

BRAIN DEPTH STIMULATION; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COGNITIVE DEFECT; DISEASE SEVERITY; GLOBUS PALLIDUS; HUMAN; HYPOPHYSIS INTERMEDIATE LOBE; MEDICAL CARE; MOTOR DYSFUNCTION; NEUROLOGIC DISEASE; NEUROSURGERY; PARKINSON DISEASE; PARKINSONISM; PATIENT COUNSELING; PATIENT SAFETY; PATIENT SELECTION; PRIORITY JOURNAL; QUALITY OF LIFE; SHORT SURVEY; SUBTHALAMIC NUCLEUS; TREATMENT INDICATION; TREATMENT RESPONSE; TREMOR; METHODOLOGY; NOTE;

ANTIPARKINSON AGENTS; DEEP BRAIN STIMULATION; HUMANS; PARKINSON DISEASE;

EID: 77957930431     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2010.128     Document Type: Short Survey

References (6)

1. Williams, A. et al. Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD sURG trial): a randomized, open-label trial. Lancet Neurol. 9, 581-591 (2010).
2. weaver, F. et al. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease. JAMA 301, 63-73 (2009)
3. Deuschl, G. et al. A randomized trial of deep-brain stimulation for Parkinson's disease. N. Engl. J. Med. 355, 896-908 (2006)
4. Moro, e. et al. Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease. Mov. Disord. 25, 578-586 (2010).
5. Gervais-Bernard, H. et al. Bilateral subthalamic nucleus stimulation in advanced Parkinson's disease: five year follow-up. J. Neurol. 256, 225-233 (2009)
6. Schüpback, w. M. et al. stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow up. J. Neurol. Neurosurg. Psychiatry 76, 1640-1644 (2005).